Detail page

Knowledge Web

Person

Halvard Bönig (1967-)

Arzt

Name	Halvard Bönig
Time	1967- (Date of birth and death)
Place	Deutschland
Academic degree	Prof. Dr.
Profession	Arzt (characteristic profession) Hochschullehrer
Variant	Halvard-Björn Bönig Halvard-B. Bönig Halvard Bonig H. Bönig H. Bonig
Related	Goethe-Universität Frankfurt am Main. Fachbereich Medizin
Further information	Arzt für Kinderheilkunde und Jugendmedizin, Arzt für Transfusionsmedizin; Habil. Fach Experimentelle Hämatologie an der Univ. Frankfurt
Record type	Person
GND-Identifier	120496100
Record ID	120496100
Involved in show all Correction: Real‑world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC‑FFM in ruxolitinib‑refractory acute graft‑versus‑host disease Interferon regulatory factor 4 plays a pivotal role in the development of aGVHD-associated colitis Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease Der Einfluss von Trauma-aktiviertem platelet-rich fibrin auf mesenchymale Stammzellen in vitro Entwicklung eines innovativen Testsystems für die Detektion, Spezifikation und Depletion von erythrozytären, thrombozytären, granulozytären und therapeutischen Antikörpern Impact of mesenchymal stromal cell–derived vesicular cargo on B-cell acute lymphoblastic leukemia progression Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease Validation of an ICH Q2 compliant flow cytometry-based assay for the assessment of the inhibitory potential of mesenchymal stromal cells on T cell proliferation Neoantigen reactive T cells correlate with the low mutational burden in hematological malignancies SARS‐CoV‐2‐specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID‐19 vaccination Superior physical and mental health of healthy volunteers before and five years after mobilized stem cell donation Zelltherapie in den Zeiten von SARS-CoV-2 A new perspective for bone tissue engineering: human mesenchymal stromal cells well-survive cryopreservation on β-TCP scaffold and show increased ability for osteogenic differentiation Frequent whole blood donations select for DNMT3A variants mediating enhanced response to erythropoietin SARS-CoV-2-specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID-19 vaccination Superior physical and mental health of healthy volunteers before and five years after mobilized stem cell donation CD3/CD19 Depletion for T-cell Reduction of Allogeneic Transplants: Mostly Efficient, but not Robust Absence of the CXCR4 antagonist EPI-X4 from pharmaceutical human serum albumin preparations Allogeneic transplant procurement in the times of COVID-19: Quality report from the central European cryopreservation site Generation and validation of a formula to calculate hemoglobin loss on a cohort of healthy adults subjected to controlled blood loss Absence of the CXCR4 antagonist EPI‑X4 from pharmaceutical human serum albumin preparations Allogeneic transplant procurement in the times of COVID-19: Quality report from the central European cryopreservation site Die Rolle des α4-Integrins in der Pathophysiologie des Autoimmundiabetes am Modell der spontan diabetischen NOD Maus Generation and validation of a formula to calculate hemoglobin loss on a cohort of healthy adults subjected to controlled blood loss PRMT6 activates cyclin D1 expression in conjunction with the transcription factor LEF1 Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytes Retargeting of NK-92 cells against high-risk rhabdomyosarcomas by means of an ERBB2 (HER2/Neu)-specific chimeric antigen receptor Supportive care during pediatric hematopoietic stem cell transplantation: prevention of infections - a report from workshops on supportive care of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) Donor-intrinsic variables determine mobilization efficiency: analyses from a cohort of sixty twice-mobilized stem cell donors The transcription factor TAL1 and miR-17-92 create a regulatory loop in hematopoiesis Correction: ABO incompatibile graft management in pediatric transplantation Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytes Correction: Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) Adaptive immunity and pathogenesis of diabetes: insights provided by the α4–integrin deficient NOD mouse Characterizing the motility of chemotherapeutics-treated acute lymphoblastic leukemia cells by time-lapse imaging Children and adults with Refractory acute Graft-versus-Host Disease respond to treatment with the Mesenchymal Stromal cell preparation “MSC-FFM”—Outcome report of 92 patients Directed differentiation of mobilized hematopoietic stem and progenitor cells into functional NK cells with enhanced antitumor activity ERBB2-CAR-engineered cytokine-induced killer cells exhibit both CAR-mediated and innate immunity against high-risk rhabdomyosarcoma Exploration of the physiological role of the endogenous CXCR4 inhibitor EPI-X4 on hematopoiesis and immunology in mice Genome-wide DNA methylation profiling in early stage I lung adenocarcinoma reveals predictive aberrant methylation in the promoter region of the long noncoding RNA PLUT: an exploratory study Highly efficient generation of transgenically augmented CAR NK cells overexpressing CXCR4 Introduction of principles of blood management to healthy donor bone marrow harvesting Mesenchymal stromal cells for osteonecrosis Potential hyperaktiver Gerinnungsfaktor IX Varianten für den Einsatz in der Hämophilie B Therapie Reducing the red blood cell transfusion threshold from 8·0 g/dl to 7·0 g/dl in acute myeloid leukaemia patients undergoing induction chemotherapy reduces transfusion rates without adversely affecting patient outcome Untersuchung FLT3-ITD-abhängiger Signalsignaturen in der akuten myeloischen Leukämie Neonatal myocardial infarction: substantial improvement of cardiac function after autologous bone marrow-derived cell therapy Cancer-induced inflammation and inflammation-induced cancer in colon: a role for S1P lyase Clinical Use of Mesenchymal Stromal Cells in the Treatment of Acute Graft-versus-Host Disease Albumin modifies responses to hematopoietic stem cell mobilizing agents in mice Children and adults with refractory acute graft-versus-host disease respond to treatment with the mesenchymal stromal cell preparation "MSC-FFM"—outcome report of 92 patients Einfluss einer CXCR4 gain-of-function Mutation auf die (un)reife Hämatopoese Functional dominance of CHIP-mutated hematopoietic stem cells in patients undergoing autologous transplantation FUSE binding protein 1 (FUBP1) expression is upregulated by T-cell acute lymphocytic leukemia protein 1 (TAL1) and required for efficient erythroid differentiation Hematopoietic-extrinsic cues dictate circadian redistribution of mature and immature hematopoietic cells in blood and spleen Improving clinical manufacturing of IL-15 activated cytokine-induced killer (CIK) cells Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) CAR T-cells targeting FLT3 have potent activity against FLT3−ITD+ AML and act synergistically with the FLT3-inhibitor crenolanib Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM) Autologous cell-based therapy for treatment of large bone defects: from bench to bedside

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Halvard Bönig (1967-)

Correction: Real‑world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC‑FFM in ruxolitinib‑refractory acute graft‑versus‑host disease

Interferon regulatory factor 4 plays a pivotal role in the development of aGVHD-associated colitis

Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease

Der Einfluss von Trauma-aktiviertem platelet-rich fibrin auf mesenchymale Stammzellen in vitro

Entwicklung eines innovativen Testsystems für die Detektion, Spezifikation und Depletion von erythrozytären, thrombozytären, granulozytären und therapeutischen Antikörpern

Impact of mesenchymal stromal cell–derived vesicular cargo on B-cell acute lymphoblastic leukemia progression

Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease

Validation of an ICH Q2 compliant flow cytometry-based assay for the assessment of the inhibitory potential of mesenchymal stromal cells on T cell proliferation

Neoantigen reactive T cells correlate with the low mutational burden in hematological malignancies

SARS‐CoV‐2‐specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID‐19 vaccination

Superior physical and mental health of healthy volunteers before and five years after mobilized stem cell donation

Zelltherapie in den Zeiten von SARS-CoV-2

A new perspective for bone tissue engineering: human mesenchymal stromal cells well-survive cryopreservation on β-TCP scaffold and show increased ability for osteogenic differentiation

Frequent whole blood donations select for DNMT3A variants mediating enhanced response to erythropoietin

SARS-CoV-2-specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID-19 vaccination

Superior physical and mental health of healthy volunteers before and five years after mobilized stem cell donation

CD3/CD19 Depletion for T-cell Reduction of Allogeneic Transplants: Mostly Efficient, but not Robust

Absence of the CXCR4 antagonist EPI-X4 from pharmaceutical human serum albumin preparations

Allogeneic transplant procurement in the times of COVID-19: Quality report from the central European cryopreservation site

Generation and validation of a formula to calculate hemoglobin loss on a cohort of healthy adults subjected to controlled blood loss

Absence of the CXCR4 antagonist EPI‑X4 from pharmaceutical human serum albumin preparations

Allogeneic transplant procurement in the times of COVID-19: Quality report from the central European cryopreservation site

Die Rolle des α4-Integrins in der Pathophysiologie des Autoimmundiabetes am Modell der spontan diabetischen NOD Maus

Generation and validation of a formula to calculate hemoglobin loss on a cohort of healthy adults subjected to controlled blood loss

PRMT6 activates cyclin D1 expression in conjunction with the transcription factor LEF1

Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytes

Retargeting of NK-92 cells against high-risk rhabdomyosarcomas by means of an ERBB2 (HER2/Neu)-specific chimeric antigen receptor

Supportive care during pediatric hematopoietic stem cell transplantation: prevention of infections - a report from workshops on supportive care of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Donor-intrinsic variables determine mobilization efficiency: analyses from a cohort of sixty twice-mobilized stem cell donors

The transcription factor TAL1 and miR-17-92 create a regulatory loop in hematopoiesis

Correction: ABO incompatibile graft management in pediatric transplantation

Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytes

Correction: Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Adaptive immunity and pathogenesis of diabetes: insights provided by the α4–integrin deficient NOD mouse

Characterizing the motility of chemotherapeutics-treated acute lymphoblastic leukemia cells by time-lapse imaging

Children and adults with Refractory acute Graft-versus-Host Disease respond to treatment with the Mesenchymal Stromal cell preparation “MSC-FFM”—Outcome report of 92 patients

Directed differentiation of mobilized hematopoietic stem and progenitor cells into functional NK cells with enhanced antitumor activity

ERBB2-CAR-engineered cytokine-induced killer cells exhibit both CAR-mediated and innate immunity against high-risk rhabdomyosarcoma

Exploration of the physiological role of the endogenous CXCR4 inhibitor EPI-X4 on hematopoiesis and immunology in mice

Genome-wide DNA methylation profiling in early stage I lung adenocarcinoma reveals predictive aberrant methylation in the promoter region of the long noncoding RNA PLUT: an exploratory study

Highly efficient generation of transgenically augmented CAR NK cells overexpressing CXCR4

Introduction of principles of blood management to healthy donor bone marrow harvesting

Mesenchymal stromal cells for osteonecrosis

Potential hyperaktiver Gerinnungsfaktor IX Varianten für den Einsatz in der Hämophilie B Therapie

Reducing the red blood cell transfusion threshold from 8·0 g/dl to 7·0 g/dl in acute myeloid leukaemia patients undergoing induction chemotherapy reduces transfusion rates without adversely affecting patient outcome

Untersuchung FLT3-ITD-abhängiger Signalsignaturen in der akuten myeloischen Leukämie

Neonatal myocardial infarction: substantial improvement of cardiac function after autologous bone marrow-derived cell therapy

Cancer-induced inflammation and inflammation-induced cancer in colon: a role for S1P lyase

Clinical Use of Mesenchymal Stromal Cells in the Treatment of Acute Graft-versus-Host Disease

Albumin modifies responses to hematopoietic stem cell mobilizing agents in mice

Children and adults with refractory acute graft-versus-host disease respond to treatment with the mesenchymal stromal cell preparation "MSC-FFM"—outcome report of 92 patients

Einfluss einer CXCR4 gain-of-function Mutation auf die (un)reife Hämatopoese

Functional dominance of CHIP-mutated hematopoietic stem cells in patients undergoing autologous transplantation

FUSE binding protein 1 (FUBP1) expression is upregulated by T-cell acute lymphocytic leukemia protein 1 (TAL1) and required for efficient erythroid differentiation

Hematopoietic-extrinsic cues dictate circadian redistribution of mature and immature hematopoietic cells in blood and spleen

Improving clinical manufacturing of IL-15 activated cytokine-induced killer (CIK) cells

Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

CAR T-cells targeting FLT3 have potent activity against FLT3−ITD+ AML and act synergistically with the FLT3-inhibitor crenolanib

Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM)

Autologous cell-based therapy for treatment of large bone defects: from bench to bedside